Stay updated with breaking news from Sandy Loreaux. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
~ First study to demonstrate rapid and sustained absorption of NDS1C epinephrine nasal spray compared to epinephrine intramuscular autoinjector, while offering higher and more sustained therapeutic plasma levels ~ ~ Study also found that NDS1C was...
Mallinckrodt PLC, a specialty pharmaceutical manufacturer that has filed for bankruptcy twice in the past three years, paid more than $21.7 million to three law firms ahead of its second insolvency filing last month.
Bryn Pharma, LLC, a privately held pharmaceutical company dedicated to finding a better way for patients and caregivers to treat anaphylaxis, announced today that it has expanded its leadership team as the company
The company is working towards FDA approval of its epinephrine nasal spray, named UTULY, for treating anaphylaxis. If successful, it may replace the current anaphylaxis treatment standard, which is the needle-based EPIPEN.
Bryn Pharma, a privately held pharmaceutical company focused on creating a new treatment for anaphylaxis - a life-threatening allergic reaction - not only has a new CEO and COO but also $15 million in cash as the company seeks FDA approval for its unique nasal spray.